Back
Banca Mediolanum SpA Vs. Apogee Therapeutics, Inc. Industry Stock Comparison
Buy
72
BNCDY
Banca Mediolanum SpA
Last Price:
$40.63
Seasonality Move:
10.17%
Sell
44
APGE
Apogee Therapeutics, Inc.
Last Price:
$84.40
Seasonality Move:
-11.77%
Buy
72
Banca Mediolanum SpA (BNCDY)
is a Buy
Is Banca Mediolanum SpA a Buy, Sell or Hold?
-
The current Banca Mediolanum SpA [BNCDY] share price is $40.63. The Score for BNCDY is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
BNCDY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Apogee Therapeutics, Inc. (APGE)
is a Sell
Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BNCDY Stock Price Chart
What is Banca Mediolanum SpA's stock price today?
-
The Banca Mediolanum SpA share price today is $40.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BNCDY is experiencing slight buying pressure.
APGE Stock Price Chart
What is Apogee Therapeutics, Inc.'s stock price today?
-
The Apogee Therapeutics, Inc. share price today is $84.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
BNCDY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.97 | Buy |
| Relative Strength Index (14 RSI): | 52.43 | Buy |
| Chaikin Money Flow: | 332 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.98 - 40.72) | Buy |
| Bollinger Bands (100): | (40.25 - 46.03) | Sell |
APGE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.18 | Buy |
| Relative Strength Index (14 RSI): | 64.96 | Buy |
| Chaikin Money Flow: | 432550 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.1 - 79.44) | Buy |
| Bollinger Bands (100): | (66.23 - 78.47) | Buy |
BNCDY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.32 | Buy |
| 20-day SMA: | 38.94 | Buy |
| 50-day SMA: | 42.15 | Sell |
| 200-day SMA: | 40.54 | Buy |
| 8-day EMA: | 38.97 | Buy |
| 20-day EMA: | 31.32 | Buy |
| 50-day EMA: | 18.47 | Buy |
| 200-day EMA: | 5.77 | Buy |
APGE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 79.91 | Buy |
| 20-day SMA: | 75.21 | Buy |
| 50-day SMA: | 71.36 | Buy |
| 200-day SMA: | 57.28 | Buy |
| 8-day EMA: | 80.37 | Buy |
| 20-day EMA: | 76.41 | Buy |
| 50-day EMA: | 73.33 | Buy |
| 200-day EMA: | 61.58 | Buy |
Banca Mediolanum SpA Earnings Growth & BNCDY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.
Banca Mediolanum SpA Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apogee Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||